(MENAFN- GlobeNewsWire - Nasdaq) Invest in scalable bioreactors, automation and optimized media to cut production costs and capture demand from CAR-T, stem cell and regenerative therapiesDublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Cell Expansion - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.
The global cell expansion market was valued at US$21.9 billion in 2025 and is projected to reach US$53.3 billion by 2032, expanding at a compound annual growth rate (CAGR) of 13.5%. Market growth is being supported by rising demand for cell-based therapies, continued investment in regenerative medicine and immunotherapy, advances in bioprocessing technologies, and the increasing prevalence of cancer, diabetes, cardiovascular disease, and other chronic conditions.
Cell Expansion Market Trends and Growth Drivers
Cell expansion plays a central role in biomedical research, biopharmaceutical production, drug discovery, regenerative medicine, oncology, and immunotherapy. Clinical and research applications increasingly require large volumes of viable, functional cells produced under controlled and reproducible conditions. This requirement is particularly significant for stem cell therapies and engineered immune-cell treatments, including CAR-T cell therapies.
Regenerative medicine represents a major source of market demand as researchers develop treatments intended to repair or replace damaged tissues. Successful therapeutic development depends on the ability to expand stem cells at scale while maintaining critical quality attributes and differentiation potential. In immunotherapy, manufacturers must produce sufficient quantities of modified immune cells while preserving safety, potency, and consistency throughout the production process.
The growing clinical adoption of cell-based therapies is increasing demand for scalable cell expansion systems that can support regulatory compliance and commercial manufacturing. Investments in bioprocessing infrastructure are also rising as biotechnology and pharmaceutical companies prepare for larger development pipelines and higher production volumes.
Technology Innovation Supports Scalable Cell Production
Advances in bioreactors, culture media, microcarriers, automation, and artificial intelligence are improving the efficiency and consistency of cell expansion workflows. Modern bioreactor systems provide controlled environments that regulate temperature, oxygen, nutrients, and other critical process parameters. Automated monitoring and process-control capabilities help improve reproducibility while reducing production time, labor requirements, and operational costs.
Specialized culture media are being optimized for specific cell types, supporting higher yields and improved cell quality. Microcarrier technologies enable adherent cells to grow in suspension-based environments, increasing bioreactor capacity and facilitating higher cell densities. Artificial intelligence and real-time analytics are also contributing to faster process decisions, improved quality control, and more efficient manufacturing at clinical and industrial scales.
Market Segment and Regional Outlook
The report analyzes the global cell expansion market by offering, cell type, application, end use, and geography. Offerings include consumables, instruments, culture flasks, and accessories. Cell-type coverage includes mammalian cells, microbial cells, and other cell types.
Applications covered include biopharmaceutical production, tissue culture and engineering, vaccine production, drug development, gene therapy, cancer research, stem cell research, and other applications. End-use categories include biopharmaceutical and biotechnology companies, research institutes, cell banks, and other organizations.
Consumables: The consumables segment is projected to reach US$23.2 billion by 2032, advancing at a CAGR of 13.7%. Instruments: The instruments segment is forecast to grow at a CAGR of 11% during the analysis period. United States: The U.S. cell expansion market was valued at US$6.4 billion in 2025. China: China is forecast to expand at a CAGR of 12.9%, reaching US$9.3 billion by 2032.
The geographic analysis covers the United States, Canada, Japan, China, Europe, Asia-Pacific, and the Rest of World. European coverage includes France, Germany, Italy, the United Kingdom, and the Rest of Europe, with additional insights into Latin America, the Middle East, and Africa.
Competitive Landscape
The cell expansion market report evaluates competitive activity, geographic presence, product positioning, technology development, and the strategic prospects of leading participants. Companies featured include:
Beckman Coulter, Inc. Becton, Dickinson and Company FUJIFILM Irvine Scientific, Inc. GE Healthcare Lonza Group Ltd. Merck KGaA Miltenyi Biotec GmbH STEMCELL Technologies Inc. Terumo BCT, Inc. Thermo Fisher Scientific, Inc.
Key Questions Addressed
How will the global cell expansion market evolve through 2032? Which trends, growth drivers, and market restraints will have the greatest impact? Which offerings, cell types, applications, and end-use segments present the strongest growth opportunities? How will regional and segment-level market shares change during the forecast period? Which companies are shaping the competitive landscape, and what are their future prospects?
Domain Expert Insights
The analysis incorporates perspectives from industry, enterprise, and academic specialists to provide strategic context beyond conventional secondary research. The report tracks early market signals emerging from expert discussions, company activity, conference sessions, keynote presentations, panel discussions, corporate disclosures, annual reports, institutional publications, and other validated sources.
These insights connect developing signals with broader strategic market direction, highlighting where the cell expansion industry is moving, which forces are influencing change, and which technologies and competitive developments are most likely to affect business planning. Company intelligence extends beyond market-level analysis to examine organizations participating in and shaping the competitive environment.
Market share is assessed where it provides meaningful strategic value. Because competitive structures vary by geography, the report examines selected major regions at a level of detail aligned with their individual market dynamics.
Report Benefits
Independent annual sales analysis and cell expansion market forecasts from 2025 through 2032. Detailed coverage of major geographic markets and industry segments. Assessment of key trends in regenerative medicine, immunotherapy, gene therapy, biopharmaceutical production, and cell culture technology. Competitive intelligence covering leading cell expansion companies and regional market presence. Actionable insights designed to support investment planning, market entry, product development, and revenue-growth strategies. Complimentary report updates for one year, providing access to relevant market developments.
With cell-based therapies progressing from research settings toward broader clinical and commercial adoption, demand for reliable, scalable, and compliant cell expansion technologies is expected to remain strong. Continued innovation in automation, bioreactors, culture media, process analytics, and high-density cell production will be critical to meeting future therapeutic and biomanufacturing requirements.
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment